Table 1

Age at diagnosis and at assessment and gender of participants in the leukaemia group and their sibling controls.

GroupMalesFemalesAge at diagnosis (mth)*Age at testing (mth)†Time since treatment (mth)†
*Results expressed as mean (SD).
†Results expressed as mean [range] (SD).
Patients11648.53 (16.39)116.65 [71–163] (25.41)60.1 [25–56] (20.4)
Siblings710Not applicable138.11 [68–164] (30.85)Not applicable